Arcoma AB (ARCOMA) - Total Assets
Based on the latest financial reports, Arcoma AB (ARCOMA) holds total assets worth Skr101.84 Million SEK (≈ $10.96 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Arcoma AB - Total Assets Trend (2012–2025)
This chart illustrates how Arcoma AB's total assets have evolved over time, based on quarterly financial data. Also see Arcoma AB stock valuation for the company's overall valuation and market capitalisation.
Arcoma AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Arcoma AB's total assets of Skr101.84 Million consist of 79.2% current assets and 20.8% non-current assets. Review ARCOMA total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 36.5% |
| Accounts Receivable | Skr17.62 Million | 18.2% |
| Inventory | Skr23.63 Million | 24.5% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr16.78 Million | 17.4% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Arcoma AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Arcoma AB (ARCOMA) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Arcoma AB's current assets represent 79.2% of total assets in 2025, an increase from 67.3% in 2012.
- Cash Position: Cash and equivalents constituted 36.5% of total assets in 2025, up from 0.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, a decrease from 21.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 24.5% of total assets.
Arcoma AB Competitors by Total Assets
Key competitors of Arcoma AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €408.98 Million |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
DRTECH Corporation
KQ:214680
|
Korea | ₩235.84 Billion |
|
Novacyt
PA:ALNOV
|
France | €40.28 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
Arcoma AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.12 | 2.25 | 1.67 |
| Quick Ratio | 2.14 | 1.24 | 0.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr55.70 Million | Skr38.49 Million | Skr24.34 Million |
Arcoma AB - Advanced Valuation Insights
This section examines the relationship between Arcoma AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.62 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | 20.1% |
| Total Assets | Skr96.65 Million |
| Market Capitalization | $11.70 Million USD |
Valuation Analysis
Below Book Valuation: The market values Arcoma AB's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Arcoma AB's assets grew by 20.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Arcoma AB (2012–2025)
The table below shows the annual total assets of Arcoma AB from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr96.65 Million ≈ $10.40 Million |
+20.12% |
| 2024-12-31 | Skr80.46 Million ≈ $8.66 Million |
-1.83% |
| 2023-12-31 | Skr81.96 Million ≈ $8.82 Million |
-18.31% |
| 2022-12-31 | Skr100.33 Million ≈ $10.80 Million |
+26.57% |
| 2021-12-31 | Skr79.27 Million ≈ $8.53 Million |
-16.59% |
| 2020-12-31 | Skr95.03 Million ≈ $10.23 Million |
+14.04% |
| 2019-12-31 | Skr83.33 Million ≈ $8.97 Million |
+9.25% |
| 2018-12-31 | Skr76.27 Million ≈ $8.21 Million |
+11.98% |
| 2017-12-31 | Skr68.11 Million ≈ $7.33 Million |
-4.41% |
| 2016-12-31 | Skr71.25 Million ≈ $7.67 Million |
-15.43% |
| 2015-12-31 | Skr84.25 Million ≈ $9.07 Million |
+6.37% |
| 2014-12-31 | Skr79.21 Million ≈ $8.52 Million |
+11.77% |
| 2013-12-31 | Skr70.87 Million ≈ $7.63 Million |
+3.47% |
| 2012-12-31 | Skr68.49 Million ≈ $7.37 Million |
-- |
About Arcoma AB
Arcoma AB develops, produces, and provides radiology solutions and digital x-ray systems in Sweden and internationally. The company offers solutions for x-ray systems covering radiological applications and general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. It also provides x-ray detectors; video bank; and accessories for x-ray equipment comprising live camera, advanc… Read more